Gates Package — page 1208
of 1375 pages
← p.1207 p.1209 → · this page in the original PDF · package
.com>
9PM
m>
dential and may contain sensitive information. It
2cipient. If you have received this e-mail in error
other storage devices. The National Institute of
for any statements made that are the sender's
representatives.
From: "Fauci, Anthony (NIH/NIAID) [E]"
@niaid.nih.gov>
To: "Bill Gates"
@gatesventures.com>
Cc: "Melinda French"
@mfgates.com>
Subject: RE: Our Annual Letter
Date: Fri, 29 Jan 2021 14:48:36 -0500
Importance: Normal
Thanks, Bill.
Anthony S. Fauci, MD
Director
National Institute of Allergy and Infectious Diseases
Building 31, Room 7A-03
31 Center Drive, MSC 2520
National Institutes of Health
Bethesda, MD 20892-2520
Phone:
FAX:
E-mail:
@niaid.nih.gov
The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It
should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error
please inform the sender and delete it from your mailbox or any other storage devices. The National Institute of
Allergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's
own and not expressly made on behalf of the NIAID by one of its representatives.
From: Bill Gates
@gatesventures.com>
Sent: Thursday, January 28, 2021 10:29 PM
To: Fauci, Anthony (NIH/NIAID) [E]
@niaid.nih.gov>
Cc: Melinda French
@mfgates.com>
Subject: Our Annual Letter
Tony,
We are writing to share a copy of our 2021 Annual Letter. We decided to focus entirely on the topic at the top of
everyone's mind: the pandemic.
We hope the letter gives you some reasons for optimism.
Bill & Melinda
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/1208
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| Our Annual Letter | 2021-01-28 | 1208 | |
| Our Annual Letter | 2021-01-28 | 1207–1208 | |
| RE: Our Annual Letter | 2021-01-29 | 1208 |